Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
General Physician
M.B.B.S., Certificate in Diabetes, Certified in Family Medicine, Certified Bls-American Heart Association
General Physician
M.B.B.S., Certificate in Diabetes, Certified in Family Medicine, Certified Bls-American Heart Association
Hepatobiliary and Liver Transplant Surgeon
M.B.B.S, M.D (USA)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP1
Internal Medicine Specialist
MBBS, FCPS (Medicine), MCPS-HPE Scholar, CHPE (Pakistan), OJT Infectious Diseases (UK), Diploma in Diabetes (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MCPS-HPE Scholar, CHPE (Pakistan), OJT Infectious Diseases (UK), Diploma in Diabetes (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Medicine), F.C.P.S.
Cardiologist
M.B.B.S, Dip. In (Diabetes) , F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures